Close Menu

Airbus and Boeing. Apple and Microsoft. Coca Cola and Pepsi. At his Seqonomics blog, Art Wuster points to these as examples of duopolies. He then asks: "How close the next-generation sequencing market … to being dominated by the Illumina and Life Technologies duopoly?"

While he notes Illumina has captured the largest share of the next-gen sequencing market to date, Life Tech is not so far behind — and other firms are beginning to come online.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.